中国药物警戒 ›› 2014, Vol. 11 ›› Issue (6): 340-343.

• 政策与法规研究 • 上一篇    下一篇

患者报告结局在药品不良反应报告中的应用和思考

王春婷   

  1. 国家食品药品监督管理局药品评价中心,北京 100045
  • 收稿日期:2014-03-11 修回日期:2016-02-03 出版日期:2014-06-08 发布日期:2016-03-02
  • 作者简介:王春婷,女,副主任药师,药品不良反应监测。
  • 基金资助:
    国家重点基础研究发展计划(973)中医基础理论专项资助项目(2009CB522802)。

Thought and Application of Patient-reported Outcome in the Adverse Drug Reaction Report

WANG Chun-ting   

  1. Center for Drug Reevaluation, CFDA, Beijing 100045, China
  • Received:2014-03-11 Revised:2016-02-03 Online:2014-06-08 Published:2016-03-02

摘要: 目的探索患者报告结局在药品不良反应报告中的应用。方法通过文献回顾的方法,对国外药品安全性研究中纳入患者报告结局的背景、驱动因素、当前监管情况进行了全面综述。结果目前数据收集的局限性、患者和医务人员间的不一致、通过患者能获取更丰富的信息等多个因素的驱动,且美国、英国等国家对此制定了监管措施,有效推动了患者报告结局在药品安全性研究中的应用。结论患者报告结局以患者为中心,为药品使用的效益、风险和结局的全面分析提供了丰富而宝贵的信息,可用作目前药物警戒和上市后研究的补充内容,为我国将患者报告结局的方法纳入药品安全性研究提供重要参考。

关键词: 患者报告结局, 药品不良反应, 文献回顾

Abstract: Objective To explore the application of the patient-reported outcome in adverse drug reaction report. Methods Through the method of literature review, the background, drivers, current regulatory framework of patient-reported outcome adoption in foreign drugs safety studies are comprehensively reviewed. Results Limitations with current data collection, discordance between patients and prescribers, better patient context drive the adoption of patient-report outcome effectively, as well as the regulatory measures formulated by many countries such as America and Britain. Conclusion Patient-reported outcome with patient-centered, which provides a rich and valuable information for comprehensive analysis of the effectiveness, risks and outcomes of drug use, can be used as a supplement to the current pharmacovigilance and post-marketing studies, and provides an important reference for our country to adopt patient-reported outcome in drug safety studies.

Key words: patient-reported outcome, adverse drug reactions, literature review

中图分类号: